NDC 59762-1530-2 - amlodipine besylate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59762-1530
- Requested NDC
- 59762-1530-2
- Package NDCs from labels
- 59762-1530-2
- Manufacturer
- RedPharm Drug Inc. | Pfizer Pharmaceuticals LLC | Hetero Drugs Limited
- Effective date
- 2011-08-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| amlodipine besylate - RedPharm Drug Inc. | Pfizer Pharmaceuticals LLC | Hetero Drugs Limited | RedPharm Drug Inc. | Pfizer Pharmaceuticals LLC | Hetero Drugs Limited | 2011-08-03 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 59762-1530-1 | EA - Each | 59762-1530 | 33f98858-6344-41d0-b915-1de2df042cb5 | 1 | 2012-07-24 |
| 59762-1530-2 | EA - Each | 59762-1530 | 8a32a6b4-a5fc-43e1-9f0b-8fa4525cb7bb | 1 | 2012-07-24 |
| 59762-1530-3 | EA - Each | 59762-1530 | 870fd041-5725-4d60-b332-1b412ec77377 | 1 | 2012-07-24 |
| 59762-1530-4 | EA - Each | 59762-1530 | 86429126-4c69-4d32-9aff-f6377ab760b9 | 1 | 2012-07-24 |
| 59762-1530-5 | EA - Each | 59762-1530 | b14b19c2-d0b3-4d43-8c7f-14f964865447 | 1 | 2012-07-24 |
| 59762-1530-6 | EA - Each | 59762-1530 | d3aebcb9-4905-4e50-8e8f-34b2e99e96cd | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| amlodipine besylate | ACTIVE INGREDIENT | 864V2Q084H | AMLODIPINE BESYLATE TABLET [REDPHARM DRUG INC.] | 1 | |
| amlodipine | ACTIVE MOIETY | 1J444QC288 | AMLODIPINE BESYLATE TABLET [REDPHARM DRUG INC.] | 1 | |
| anhydrous dibasic calcium phosphate | INACTIVE INGREDIENT | L11K75P92J | AMLODIPINE BESYLATE TABLET [REDPHARM DRUG INC.] | 1 | |
| cellulose, microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | AMLODIPINE BESYLATE TABLET [REDPHARM DRUG INC.] | 1 | |
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | AMLODIPINE BESYLATE TABLET [REDPHARM DRUG INC.] | 1 | |
| sodium starch glycolate type A potato | INACTIVE INGREDIENT | 5856J3G2A2 | AMLODIPINE BESYLATE TABLET [REDPHARM DRUG INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amlodipine Besylate | AMLODIPINE BESYLATE | Preferred Pharmaceuticals, Inc. | 01139e81-a4fa-4e13-acdf-c75c79a1aa9c | 2026-02-23 | Warnings, Adverse reactions | 197361 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Preferred Pharmaceuticals Inc. | 1ff04bd2-9926-48a4-9afc-eab0789dba01 | 2026-02-23 | Warnings, Adverse reactions | 864V2Q084H |
| Exforge | AMLODIPINE BESYLATE AND VALSARTAN | Novartis Pharmaceuticals Corporation | d0caec89-96ec-411d-a933-63eda74a6da7 | 2026-02-17 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Atorvastatin | AMLODIPINE AND ATORVASTATIN | Bryant Ranch Prepack | 043c4742-081d-4bc4-bf27-dad92bb2dfbc | 2026-02-12 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | REMEDYREPACK INC. | ea774c36-e970-4d9c-9487-6cc57741fec5 | 2026-02-09 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 4a2bba2d-9b7a-f43a-e063-6294a90af80e | 2026-02-06 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | Bryant Ranch Prepack | 5813e6b6-f524-4fba-99ba-9f4e365bf523 | 2026-02-06 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | Bryant Ranch Prepack | c56a384c-b250-4a43-99ce-ddd88376c817 | 2026-02-05 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | A-S Medication Solutions | 3b13554a-0f63-4238-8f55-a1400c847c9f | 2026-02-04 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Benazepril Hydrochloride | AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE | REMEDYREPACK INC. | cb87f119-1598-405f-b627-eec749c8d42c | 2026-01-29 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 41496b0d-f1ca-4e9d-e063-6394a90aec1d | 2026-01-29 | Warnings, Adverse reactions | 197361 864V2Q084H |
| Amlodipine and Olmesartan Medoxomil | AMLODIPINE AND OLMESARTAN MEDOXOMIL | A-S Medication Solutions | 350c7317-a92d-4bcb-973f-19d6de87ed83 | 2026-01-24 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| AMLODIPINE BESYLATE 5 mg | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 49104797-8202-1376-e063-6294a90adb38 | 2026-01-23 | Warnings, Adverse reactions | 197361 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 3ab4ad3d-7795-058a-e063-6294a90abc86 | 2026-01-23 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Preferred Pharmaceuticals Inc. | 743ae641-14e1-456b-80e6-c6f7d621e969 | 2026-01-16 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Preferred Pharmaceuticals Inc. | 6e038d92-09f3-4517-947e-146d007114b8 | 2026-01-14 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Olmesartan Medoxomil | AMLODIPINE AND OLMESARTAN MEDOXOMIL | AvKARE | 1b30c3fe-5c84-0d42-e063-6394a90a81d8 | 2026-01-13 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | AvKARE | feb9438a-9cbc-4855-e053-6394a90af15e | 2026-01-13 | Warnings, Adverse reactions | 197361 864V2Q084H |
| Pyrogenium Combination 9239 | PYROGENIUM COMBINATION | Professional Complementary Health Formulas | 8b869987-bfd2-4451-a2a8-ce3a92e201f2 | 2026-01-08 | Warnings | L11K75P92J |
| Pneumo Drops 5018 | PNEUMO DROPS | Professional Complementary Health Formulas | ea6d0286-db1c-48c0-83fd-c18fa8f8629f | 2026-01-08 | Warnings | L11K75P92J |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.